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Abstract
In order to test therapeutics, functional assessments are required. In pre-clinical stroke research, there is little consensus
regarding the most appropriate behavioural tasks to assess deficits, especially when testing over extended times in milder
models with short occlusion times and small lesion volumes. In this study, we comprehensively assessed 16 different
behavioural tests, with the aim of identifying those that show robust, reliable and stable deficits for up to two months.
These tasks are regularly used in stroke research, as well as being useful for examining striatal dysfunction in models of
Huntington’s and Parkinson’s disease. Two cohorts of male Wistar rats underwent the intraluminal filament model of
middle cerebral artery occlusion (30 min) and were imaged 24 h later. This resulted in primarily subcortical infarcts, with
a small amount of cortical damage. Animals were tested, along with sham and naı¨ve groups at 24 h, seven days, and one
and two months. Following behavioural testing, brains were processed and striatal neuronal counts were performed
alongside measurements of total brain and white matter atrophy. The staircase, adjusting steps, rotarod and apomor-
phine-induced rotations were the most reliable for assessing long-term deficits in the 30 min transient middle cerebral
artery occlusion model of stroke.
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Introduction
Many rodent models of focal brain ischemia exist, but
the most commonly employed is the intraluminal ﬁla-
ment middle cerebral artery occlusion (MCAO) model
of stroke.1 There is debate regarding the ability of dif-
ferent behavioural tasks to reveal reliable deﬁcits in this
model. Often rats recover sensorimotor function in the
weeks following MCAO; many groups have shown that
MCAO rats exhibit recovery or even compensation,
particularly if tested for more than seven days.2
Despite this, few studies assess behaviour for more
than a few days post-ischemia. The Stroke Therapy
Academic Industry Roundtable (STAIR) Preclinical
Recommendations highlighted that measurement of
behavioural outcomes for testing novel therapeutics
should occur for at least two to three weeks post
induction of focal ischemia.3 This is particularly
important when considering the plethora of patho-
logical changes that are occurring in the brain following
the initial event. If chronic time points are not included,
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researchers cannot be certain that any potential inter-
vention will have a long-term functional eﬀect, which
will be required for any novel therapy to progress to
testing in patients. Functional outcomes are often not
assessed until three to six months post-stroke in clinical
trials and, as in the rodent, patients often display a
degree of recovery in the ﬁrst few weeks following the
stroke. Thus, to be able to develop therapeutics which
will translate from bench to bedside, it is necessary to
ﬁnd stable long-term tests of neurological function in
animal models. These tests need to be easy to adminis-
ter, and preferably quantitative rather than qualitative
in nature to reduce the risk of bias.
In the current study, we comprehensively assessed
the MCAO ﬁlament model of stroke in rats using 16
diﬀerent behavioural tests. We evaluated tests that are
commonly used in stroke models and introduce other
tests that have proven extremely successful for detailed
assessment of striatal dysfunction in models of
Parkinson’s and Huntington’s disease. The aim was to
identify tests that are sensitive to MCAO, and which
show robust, reliable and stable deﬁcits for up to two
months. For this purpose, we chose a relatively speciﬁc
lesion model with a small infarct volume, which would
be more suitable for longer term studies of neuropro-
tective and neurorepair strategies.
Materials and methods
A brief outline of the methods is below. Full details are
provided in the supplemental methods.
Animals
Seventy-ﬁve male Wistar rats were divided into two
cohorts (10–12 weeks old; Harlan, UK) and housed in
groups of three to four, in standard cages with wood
shavings as bedding, nesting material, a tube and aspen
chew blocks. Prior to surgery, stratiﬁed randomisation
was performed and animals were assigned to sham,
naı¨ve or MCAO groups based on baseline behaviour
scores to negate any potential pre-existing diﬀerences in
the groups. Following surgery animals were kept in the
same cage groups where possible, meaning sham, naı¨ve
or MCAO animals were often housed together. The
temperature (21 2C), humidity (55 10%) and
light cycle (14/10 hour light/dark cycle) of the environ-
ment was controlled. All experiments were performed
within the same facility in accordance with the UK
Animals (Scientiﬁc Procedures) Act 1986, under a pro-
ject license approved and granted by the UK Home
Oﬃce. Experiments are reported in accordance with
the ARRIVE guidelines.
Each experiment utilised a pre-deﬁned exclusion cri-
teria: (i) no restitution of cerebral blood ﬂow (CBF)
following removal of the ﬁlament (indicative of haem-
orrhage), n¼ 15 (all from the MCAO group); (ii)
incomplete MCAO, deﬁned as absence of observable
cortical or striatal changes during MRI at 24 h, n¼ 11
(all from the MCAO group); and (iii) post-operative
weight loss of more than 20% of pre-surgical weight,
n¼ 2 (all from the MCAO group). Additionally, one
sham animal showed abnormalities at 24 h in the
MRI and two other MCAO animals had complications
during surgery. All of these animals were excluded prior
to post-surgical behavioural testing.
The remaining 44 animals were allocated as follows:
Cohort 1: 11 MCAO, 8 sham and 6 naı¨ve animals;
Cohort 2: 9 MCAO, 5 sham and 5 naı¨ve controls. The
sham and naı¨ve controls were subsequently combined to
make one control group in each cohort following com-
parison to ascertain the absence of diﬀerences between
them (supplemental methods A5). Sample sizes were
selected based on previous work with other models of
striatal injury on a selection of tasks, and with the
rational that if deﬁcits were not robust with these
group sizes then studies for treatments, which would
require signiﬁcantly larger groups, would not be feasible.
Middle cerebral artery occlusion
Sham and 30min MCAO procedures were carried
out under isoﬂurane anaesthesia, using the method
described in Trueman et al.4 to prevent damage to the
facial musculature, as described fully in the supplemen-
tal methods (A1). During the procedure, blood ﬂow
was monitored using a Laser Doppler Perfusion
Monitor (Moor Instruments, Axminster, UK).
MRI measurements and image analysis
Twenty-four hours following surgery, sham and
MCAO animals underwent a structural Multi-Slice
Multi-Echo (MSME) T2-weighted MRI scan using a
9.4TBiospec with a rat head surface coil (Bruker
BioSpin, Ettlingen, Germany). Analyze software
(AnalyzeDirect, Overland Park, USA) was used to
delineate manually the infarct and T2 values (ms)
were recorded, as described fully in the supplemental
methods (A2).
Behavioural testing
Methods and full protocols are provided for each
behavioural test in the online supplemental data
(Sections A and C), including practical advice and
troubleshooting tips (C). All behavioural testing was
performed by a blinded observer. Two cohorts of rats
were used to reduce the number of tests each rat was
exposed to.
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Food restriction
Cohort 1 required food restriction to perform the food
reward tasks. Their body weight was maintained at
85–90% of free feeding weight, by giving restricted
amounts of food daily. This commenced one week
prior to baseline training and rats were returned to ad
libitum feeding a week prior to surgery until three days
prior to the commencement of testing at four weeks
post-MCAO.
Experimental design
All rats were trained on the behavioural tasks prior to
surgery and were tested at one and seven days, and one
(4–5 weeks) and two months (8–9 weeks) post-MCAO
(Figure 1). Behavioural testing was carried out between
the hours of 8 a.m. and 7 p.m. and animals were tested
in cage order.
Following MCAO, both cohorts were tested for less
than 12min a day, with an extra 15min a day for 25
days when Cohort 1 was tested on the staircase task,
and an extra 150min of drug-induced rotations (apo-
morphine & amphetamine) at the end of the study for
Cohort 2.
Tissue processing and immunohistochemistry
As described fully in the supplemental methods (A4),
following perfusion ﬁxation brains were sectioned and
stained for NeuN (1:4000, Chemicon, UK) and solo-
chrome cyanine (Sigma Aldrich, UK5) to allow visual-
ization of neuronal nuclei and white matter tracts,
respectively. Sections were digitally photographed to
determine ﬁnal tissue and white matter loss using
Image J (NIH, USA).
Atrophy was calculated as
Whole brain atrophy ¼ 100 Hc Vcð Þð
 Hi Við ÞÞ= Hc Vcð Þ ð1Þ
White matter atrophy ¼ 100 WcWið Þ=Wc ð2Þ
where H, V, W, i, and c represent the volumes of the
contralateral (c) and ipsilateral (i) hemisphere (H), ven-
tricle (V), and white matter-stained (W) areas.
Additionally, stereological neuronal counts of the
entire right striatum of a 1 in 12 series using the
Olympus C.A.S.T. grid system v1.6 were performed
to estimate the total neuronal count for the striatum.
One MCAO and one control animal from Cohort 1 and
Figure 1. Outline of the experimental design and tasks performed by Cohort 1 and 2.
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one control animal from Cohort 2 were excluded from
the histological analysis due to tissue damage.
Statistical analysis
For full details of statistical analysis, see the supple-
mental methods (A5). Brieﬂy, behavioural data were
tested for normality, and those measures which were
normally distributed (rotarod, balance beam (latency
to cross), corridor and gripstrength (force)) were ana-
lysed using a repeated measures ANCOVA, with base-
line performance used as a co-variate. Those measures
that were not normally distributed were analysed using
the non-parametric Mann–Whitney test. Simple com-
parisons for normally distributed histological data were
analysed using Student’s t-tests.
Results
Neuropathology
The lesions-induced cell loss in the lateral neocortex
and striatum on the side of the infarction and atrophy
of the hemisphere. The T2 maps indicated greater vari-
ability in the extent of the hyperintensity in Cohort 1
(Figure 2(f)) than Cohort 2 (Figure 2(g)), although this
was not signiﬁcant (Figure 2(a), U¼ 31, n.s.). Similarly,
the MCAO-lesioned animals in the two Cohorts did not
exhibit signiﬁcantly diﬀerent infarct volumes (i.e. hemi-
spheric atrophy), striatal or hemispheric white matter
loss, or striatal neuronal loss (Figure 2(b) to (e);
t17¼ 1.37, t17¼ 1.90, U¼ 25 and t17¼ 0.05, respectively,
all n.s.).
Behavioural measures
For clarity of presentation, we have grouped the tests
into four diﬀerent broad categories: tests in which
robust long-term deﬁcits were observed in MCAO ani-
mals, tests in which the impairment was subtle and/or
recovered spontaneously, tests in which the results were
counter-intuitive, and tests in which no signiﬁcant
impairments in MCAO animals were observed.
Tests that uncovered significant and stable deficits
in the MCAO animals
Staircase task. MCAO rats collected fewer pellets
with their contralateral paw, than the corresponding
paw in the Control group, on the staircase test at two
months post-surgery (Figure 3(a): Blocks 2–4:
U¼ 38–41, p< 0.05, Block 5: U¼ 45, p¼ 0.08), whereas
they showed no deﬁcits in the number of pellets
retrieved on the ipsilateral side (U¼ 59–74, n.s.).
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Figure 2. Assessment of MCAO neuropathology in Cohorts 1 and 2. (a) Hyperintense volume on MRI at 24 h post MCAO surgery.
(b) Percentage of hemispheric atrophy from histology at two months. (c) Percentage of striatal white matter atrophy, and (d)
Percentage of total hemisphere white matter atrophy calculated from solochrome cyanine stained sections at two months. (e) Striatal
NeuN cell loss as a percentage of the total number of cells in the Control group. (f) and (g) Representative T2 maps from animals in
Cohorts 1 and 2, respectively. All graphs show mean standard deviation (SD), n¼ 11 and 9 for MRI and 10 and 9 for all other
measures. No signifcant differences were found between the two Cohorts.
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Apomorphine-induced rotation. The MCAO animals
exhibited a signiﬁcant increase in the number of rota-
tions to the ipsilateral side in response to apomorphine;
this was in contrast to no net asymmetry in rotations in
the Control animals (MCAO, 189.0 169.3 vs.
Controls, 3.4 9.23 (Mean SD); U¼ 14, p< 0.01).
Tests in which the MCAO animals exhibited subtle deficits
and/or recovery
Rotarod. Latency to fall oﬀ the Rotarod was signiﬁ-
cantly lower in the MCAO group when compared
to the Control (Figure 3(b), F1,22¼ 6.59, p< 0.05).
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Figure 3. Summary of tests in which MCAO animals exhibited deficits. (a) Pellets retrieved with each forelimb in the staircase task at
two months (Cohort 1: n¼ 14 Control, n¼ 11 MCAO). (b) Latency to fall from the Rotarod at one and two months (Cohort 1:
n¼ 14 Control, n¼ 11 MCAO). (c) Forehand and backhand steps during lateralized stepping (both cohorts at one day: n¼ 19 Control,
n¼ 20 MCAO, at seven days: n¼ 19 Control, n¼ 19 MCAO, at one month: n¼ 23 Control, n¼ 18 MCAO, and at two months: n¼ 24
Control, n¼ 20 MCAO). (d) Modified neuroscore (both cohorts: n¼ 24 Control, n¼ 20 MCAO). (e) Time to criterion and number of
failed reaches in the cage reaching task at one and two months (Cohort 1: at 1 mo: n¼ 13 Control, n¼ 11 MCAO, at two months:
n¼ 13 Control, n¼ 11 MCAO). (f) Bias in the corridor task at one and two months (Cohort 1: n¼ 14 Control, n¼ 11 MCAO). (g)
Latency to respond with and without the chocolate distractor in the disengage task (Cohort 2: n¼ 10 Control, n¼ 9 MCAO, except
at one month with chocolate distractor for the contralateral paw: n¼ 10 Control, n¼ 8 MCAO). (h) Latency to cross for regular and
irregular rungs in the ladder test at one and two months (Cohort 2: n¼ 10 Control, n¼ 9 MCAO). Data are expressed as median,
minimum and maximum values in the box and whisker plots and as means standard deviation (SD) with individual values in
the scatter plots. Note: the dotted line represents 50% bias (no preference for either side or paw). *¼ p< 0.05, **¼ p< 0.01,
*** p< 0.001.
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This deﬁcit appeared to increase over time
(MCAOTime: F1,23¼ 8.95, p< 0.01) such that the
post hoc comparison between groups was only signiﬁcant
on the two-month time point (p< 0.05). However, this
eﬀect was not due to a further decrease in performance
in the MCAO group, but rather an improvement in the
ability to remain on the Rotarod in the Control group.
Lateralized stepping. The MCAO rats exhibited a
paw bias, meaning they performed fewer steps with
the contralateral paw than with the ipsilateral paw,
although this deﬁcit was not stable across all time
points. They had a paw bias in the forehand direction
at one day and two months (Figure 3(c), U¼ 72,
p< 0.001, U¼ 100.5, p< 0.001) and in the backhand
direction at seven days and one month (Figure 3(c),
U¼ 105, p< 0.05, U¼ 114, p< 0.01).
Modified neuroscore. The score diﬀered between
MCAO and Control groups at one and seven days
post-MCAO (Figure 3(d); U¼ 104.0 and 123.5, respect-
ively, both p< 0.01); at both time points, the MCAO
animals scored higher (indicating reduced neurological
function overall) but this was no longer the case at one
and two months (U¼ 212.5 and 162.0, respectively,
both n.s.).
Cage reaching task. MCAO rats took longer to
achieve 20 successful reaches than Control animals at
one month (Figure 3(e), U¼ 28, p< 0.05). However, no
other measures achieved signiﬁcance.
Corridor task. MCAO animals retrieved fewer pel-
lets from the contralateral side in the corridor task at
both one and two months after surgery, in comparison
to the absence of a side preference in the Control group.
However, this diﬀerence did not achieve signiﬁcance
(Figure 3(f), Groups, F1,22¼ 4.14, p¼ 0.054).
Disengage task. Overall a larger response time to
both contralateral and ipsilateral perioral stimulation
without the chocolate distraction was evident in the
MCAO group in comparison to the Control group at
one month (Figure 3(g), Contra: U¼ 15.50, p< 0.05,
Ipsi: U¼ 13, p< 0.01), but not at two months
(U¼ 43, 29, n.s.). When the chocolate distraction was
introduced, there was a signiﬁcantly higher response
time to perioral stimulation in the MCAO group on
the ipsilateral side in comparison to the Control
group at one month (U¼ 11, p< 0.01) and two
months (U¼ 10, p< 0.01).
Ladder test. On the regular spaced rungs in the
ladder task, there was a small but signiﬁcant increase
in the number of hindpaw slips exhibited by the MCAO
group at one month (Control 0.0 0.0, MCAO
0.08 0.08 (MeanSD); U¼ 20, p< 0.05). However,
there was also a reduction in forepaw slips in the
MCAO group at one month (Control 0.50 0.40,
MCAO 0.20 0.36 (Mean SD); U¼ 20.5, p< 0.05).
It should be noted that the number of overall foot
slips made on the ladder with regular rungs was
very low (means of 0.1–0.5 slips per traverse)
and both groups crossed relatively quickly (10–12 s;
Figure 3(h)). In comparison, rats took almost twice as
long to cross the ladder with irregularly spaced rungs
(Figure 3(h), 18–25 s). This slowing was most apparent
in the MCAO group, but failed to achieve signiﬁcance
(U¼ 29 & 24, n.s.).
Tests in which the results were counter-intuitive.
Swimming analysis. There were no signiﬁcant diﬀer-
ences in the number of fore or hindlimb strokes per-
formed by the MCAO animals on either side when
compared to the corresponding paws from the Control
group (Figure 4(a), U¼ 24–44, n.s.). However, the
MCAO animals were signiﬁcantly faster at crossing the
swim tank than the control animals (1 month: 2.26 0.37
vs 2.82 1.77 s, U¼ 10, p< 0.01. 2 month: 2.41 0.34 vs
3.03 0.81 s, U¼ 14, p< 0.01 (Mean SD))
Tapered balance beam. The MCAO group made sig-
niﬁcantly fewer contralateral forelimb slips on the beam
in comparison with the control group at two months
(Figure 4(c); U¼ 20.5, p< 0.05). However, MCAO ani-
mals were no faster in their latencies to cross the beam
(F1,15¼ 3.57, n.s).
Gait analysis. A number of measures of gait were
assessed. Distance between forepaws (base width) was
unaltered in the MCAO group compared to the
Control group (Figure 4(d); n.s.). Hindlimb base
width (distance between the two hind limbs) was nar-
rower in the MCAO group than the Control rats at one
month only (Hind base width, Figure 4(d): U¼ 14,
p< 0.05). Overlap of hind and forepaws during the
walking cycle appeared to be reduced in the MCAO
animals in comparison to the Control rats; however,
this only achieved signiﬁcance on the ipsilateral side
at one month (U¼ 18, p< 0.05). Additionally, stride
length was only signiﬁcantly increased in the MCAO
group in comparison to the Control group at the one-
month time point (Figure 4(d); U¼ 13.5, p< 0.05).
Grip strength. The MCAO group required signiﬁ-
cantly more force than control animals to release the
bars at both one and two months (Figure 4(e); Groups;
F1,22¼ 4.36, p< 0.05). Moreover, they exhibited no sig-
niﬁcant asymmetry between the two grip strength bars
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(Bias: n.s.) indicating no diﬀerence in grip strength
between sides.
Tests in which the MCAO animals did not exhibit significant
deficits.
Amphetamine-induced rotations. Neither group
exhibited any rotational asymmetries in response to
amphetamine (net rotations: Control: 7.10 46.75 vs.
MCAO: 8.22 121.2, (MeanSD); n.s.).
Adhesive removal. The adhesive removal (‘sticky
label’) test of somatosensory neglect showed no diﬀer-
ences between groups at either time point (one or two
months) in either the latency to contact or remove the
labels aﬃxed to either of their forepaws (Figure 4(f)).
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Cylinder task. Although there appeared to be a
small contralateral deﬁcit in paw placing on the
surface of the cylinder among the MCAO animals
at one day, this was not signiﬁcant and no signiﬁ-
cant bias in forelimb exploratory use was observed
at any of the other post-surgical time points (Figure
4(b))
Correlations of behavioural data with histological/MRI
measures. A multiple correlational analysis was under-
taken between the most robust tests (staircase task and
apomorphine rotations), those that would be of utility
(rotarod and lateralized stepping), and the ﬁve meas-
ures of neuropathology (MRI hyperintensity; hemi-
spheric, total white matter and striatal white matter
atrophy; and striatal neuronal number). Individual
results are summarised in Supplementary Table S1.
Apomorphine-induced rotations, rotarod and forehand
lateralised stepping did not correlate with histological
measures. In the staircase reaching test, the number of
pellets retrieved on the contralateral side over the last
ﬁve days of training correlated positively with the
number of surviving striatal neurons (r¼ 0.8,
p< 0.01), and the hyperintense region on the MRI
(r¼0.63, p< 0.05). Additionally, the hyperintense
region of the MRI signiﬁcantly correlated will all
neuropathological measures apart from the number
of ipsilateral striatal neurons (r¼ 0.58–.72, p
all< 0.01).
Discussion
This extensive comparison of the most common tests
for assessing motor and sensorimotor function follow-
ing MCAO in rats has provided some interesting
results. We consider that the most useful way of sum-
marizing the tests is to rank them in terms of utility
according to the underlying aim, which was to identify
tests that are suitable at long-term time points in order
to monitor stable deﬁcits and the eﬀects of potential
therapeutics. Therefore, the tests were split into four
categories: those which uncovered robust long-term
deﬁcits for up to two months in MCAO animals,
those in which MCAO animals exhibited subtle impair-
ments but were not stable across time, those which
failed to detect deﬁcits in MCAO animals, and those
in which the results appeared to be counter-intuitive,
but still of potential utility. For a summary of this see
Table 1. In order to further inform on the usefulness of
these tests and assist in the design of future experi-
ments, we performed sample size calculations on our
data to compute group sizes required in order to
observe a deﬁcit in MCAO animals when compared
to Controls at two months for tests/measures that
were not signiﬁcant in this study (Table 2). This was
taken a step further for the tests we deemed most
useful, and sample size calculations were performed
on the MCAO data compared to a hypothetical
MCAO group in which a 50% treatment eﬀect would
be required (Table 3).
Table 1. Summary of results. The tests in bold detected significant differences between the control and MCAO groups.
1 day 7 days 1 month 2 months
Both cohorts Modified neurological
score
lateralized stepping
Modified neurological
score
lateralized stepping
Modified neurological score
lateralized stepping
Modified neurological
score
lateralized stepping
Cohort 1 Cylinder task Cylinder task Cylinder task
Cage reaching
Grip strength
Rotarod
Corridor task
Cylinder task
Cage reaching
Grip strength
Rotarod
Corridor task
staircase task*
(*on days 38 to 63)
Cohort 2 Tapered balance beam
Disengage task
Gait analysis
Ladder test
Adhesive removal
Swimming analysis
Tapered balance beam
Disengage task
Gait analysis
Ladder test
Adhesive removal
Swimming analysis
Drug-induced rotations:
Apomorphine,
Amphetamine
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Robust tests
Apomorphine-induced rotations robustly detected
rotational bias in the MCAO animals at two
months, which is consistent with other reports.6 The
variability of this test was low, and as such achiev-
able group sizes (n¼ 50, Table 3) would be required
in order to test a therapeutic intervention. However,
the interaction between apomorphine with any ther-
apy should be carefully considered. The other test
that proved to be useful at long-term time points
was skilled reaching using the staircase chambers.
This is not entirely surprising as skilled reaching
requires a high degree of motor coordination and
tests like this have been consistently used by several
groups to reveal subtle impairments and compensa-
tory behaviours in many diﬀerent animal models of
neurological disease and degeneration.7
Unfortunately, tests such as these are not routinely
used in pre-clinical stroke research. This might be due
to the fact that pre-training the animals to perform in
the test apparatus can be quite labour intensive and
may extend over several weeks in order to ﬁrst
achieve stable baseline performance. Furthermore,
there is the additional requirement of food restriction
in order to motivate the animals to perform. This
may conﬂict with the ability of this test to be
employed in the acute MCAO post-operative period
and may render the tests undesirable for many
groups. Furthermore, as food restriction has been
shown to induce long-term alterations in rodents,
which may be beneﬁcial, such as improving behav-
ioural Furthermore, enhancing neuroprotection and
increasing longevity.8,9 As is the case with the major-
ity of behavioural assessments, there is variability
between animals, so large group sizes are often
required and this can be even more discouraging
with tests that require large investment such as skilled
reaching. Within our study, the staircase deﬁcit was
stable across blocks 2–4 of training, and approached
signiﬁcance on block 5. Therefore, it would be rec-
ommended to increase the sample size for this test,
indeed large group sizes would be required for testing
treatments (Table 3). A second type of skilled reach-
ing, caged skilled reaching, did not reveal stable def-
icits. This may have been due to the variability of the
data and the propensity of the rodents to compensate
by using the non-aﬀected paw (a factor that is not
contributing in the staircase task where pellets on
each side of the body can only be retrieved with
the corresponding paw). As well as increasing the
group size to account for this variability (n¼ 37,
Table 2), some groups lesion the side of the brain
that corresponds to the preferred paw of each indi-
vidual rodent.
Table 2. Sample size calculations for MCAO versus Control,
based on the variance and difference between groups at the 2
month time point. Power¼ 0.8, a¼ 0.05.
Test Measure
Sample size
(per group)
Gait analysis Hind paw base width 24
Disengage with
distractor
Latency (contralateral) 31
Tapered balance beam Latency 33
Modified neuroscore 36
Cage reaching Latency to criterion 37
Corridor Bias 38
Irregular ladder Latency 44
Cage reaching Failed reaches
(contralateral)
59
Adhesive removal Bias (remove) 208
Drug-induced rotations Amphetamine 473
Disengage without
distractor
Latency
(contralateral)
552
Cylinder Bias 818
Adhesive removal Bias (contact) 1137
Regular ladder Hind foot slips 10748
Table 3. Sample size calculations for MCAO versus treated
MCAO (with anticipated 50% in improvement) based on the
variance and difference between groups at the 2 month time
point. Power¼ 0.8, a¼ 0.05.
Test Measure
Sample size
(per group)
Swimming analysis Latency 20
Rotarod Latency 27
Drug-induced rotations Apomorphine 50
Lateralised stepping Bias (forehand) 66
Staircase reaching Pellets retrieved
(contralateral)
84
Gait analysis Hindpaw base width 87
Irregular ladder Latency 107
Tapered balance beam Latency 124
Corridor Bias 145
Disengage with distractor Latency
(contralateral)
168
Modified neuroscore 168
Cage reaching Latency to criterion 277
Gripstrength (AU) 279
Cage reaching Failed reaches
(contralateral)
394
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Tests in which MCAO animals exhibited
subtle or transient impairments
A number of tests showed impairments at some time
points, and therefore could potentially be of utility with
increased groups sizes or additional training. The
rotarod has been used for detecting deﬁcits in the
MCAO animals by many groups,10,11 and the data pre-
sented here supports this. At one month, the MCAO
group was just shy of being signiﬁcantly diﬀerent from
the Controls, though a signiﬁcant diﬀerence was evi-
dent at two months. Care in interpretation of these
data is crucial: performance was stable in the MCAO
group at both time points, whereas performance
improved in the Control animals, indicating a signiﬁ-
cant degree of motor learning in the latter group.12
Therefore, it may be advantageous to expose the
animals to extra training until stable/asymptotic per-
formance is achieved both prior to and following sur-
gery. Based on the two-month data, a sample size of
only 27 (Table 3) would be required to detect a treat-
ment eﬀect. The corridor task, which is highly sensitive
in rodent models of Parkinson’s disease,13 appeared to
be somewhat useful for assessing deﬁcits in the MCAO
group as there was a slight bias that only just failed to
achieve signiﬁcance. Indeed, we have repeated this test
in other groups of MCAO rats with 60min occlusion
and found that it is discriminatory between MCAO and
Control rats. Based on the current data, sample size
calculations indicate that group sizes of 38 animals
would be required to observe deﬁcits between Control
and MCAO rats.
Lateralized stepping was not consistent across all
time points. Making adjusting steps in the forehand
direction proved to be most diﬃcult for MCAO rats
at one day and two months: the same has been shown
for the forelimb direction after distal MCAO (that
aﬀects only the cortex) out to eight weeks.14
Backhand adjustment steps were most diﬃcult at
seven days and one month. Diﬀerent measures from
this task did reveal deﬁcits across all time points, and
as such, it should not be ruled out, particularly since
this test is simple to administer.15 The disengage task
has been shown to reveal robust deﬁcits in other animal
models of striatal or nigro-striatal injury.16 The ability
to ‘disengage’ from feeding when exposed to a sensory
stimulus (cotton bud stimulating the perioral region) on
either side (impaired or intact) was examined and, an
unexpected ipsilateral deﬁcit was evident with the choc-
olate distractor, unlike studies which have utilised this
test in models of Parkinson’s disease.17 However, a dif-
ference was also evident on the contralateral side at one
month, which just failed to achieve signiﬁcance, and it
is possible that an increase in sample size may resolve
this (n¼ 31, Table 2).
In the modiﬁed neuroscore, an increased score was
seen in the MCAO group at one and seven days; how-
ever, this resolved by one month post-MCAO. This is
in line with other studies that show a high degree of
recovery in neurological scores with time.18,19 While
this test may detect deﬁcits under certain conditions,
for example in the short term after stroke, one major
concern with employing tests in which there is spontan-
eous recovery is that, if a beneﬁt from a therapeutic
intervention is seen acutely post-MCAO, the experi-
menter will not know whether the treatment has truly
improved functional capacity or has simply accelerated
the spontaneous recovery which will naturally occur
over the coming weeks. The ladder test was assessed
at one and two months and did not consistently show
strong deﬁcits. While the MCAO rats made more hind-
paw slips and less forepaw slips on the regular spaced
rungs at one month, the overall number of foot slips
was very low, indicating the rats did not struggle to
cross. While a slight but non-signiﬁcant increase in
latency to cross the ladder was observed in both
groups when the task was made increasingly diﬃcult
by spacing the rungs irregularly, the number of overall
foot slips under this condition remained low.
Counter-intuitive tests
A few tests provided results that may be considered
unexpected or contrary to the initial hypothesis. On
both the tapered balance beam and gait analysis, per-
formance of the MCAO animals was signiﬁcantly
better at some time points compared to the Control
group. For example, while the time to cross the tapered
balance beam did not diﬀer between the groups, the
MCAO rats produced signiﬁcantly less hindpaw slips
at one month. This was surprising, as the presence of
the supporting ledge is thought to alleviate the fear
associated with foot slips – which might otherwise
lead to a fall – and thus deﬁcits may be exaggerated.
However, this may be explained by taking into account
the results of the gait analysis, which showed the
MCAO rats had a reduced hindpaw base width at
one month, with a trend towards the same decrease at
two months. While this is also unexpected (an increased
base width has been associated with MCAO at longer
time points20), the reduced base width might mean that
the rats are less likely to slip, as the hindlimbs are fur-
ther away from the edge of the beam. It is possible that
this decrease in base width is a compensatory mechan-
ism together with the increase in stride length. Indeed,
in addition to a reported increase in base width, other
groups have reported a mild decrease in stride length
using a catwalk system in rats with occlusion durations
of 60min or more.18,20 Thus, the duration of occlusion
used in the present study may not have been suﬃcient
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to induce the magnitude of damage required to produce
the same changes in parameters of gait. We also did not
examine body weight as a potential confound, as was
the case in the previous experiments.
Swimming behaviour also provided interesting
results. The MCAO rats made slightly more corrective
fore paw strokes with the impaired forelimb at one
month. Though this did not achieve signiﬁcance, it
has been reported previously and is often attributed
to disinhibition of the forepaws which are not normally
used for swimming in rats.21 However, MCAO rats did
exhibit an increase in swim speed, which on the surface
might imply they are swimming better than has previ-
ously been reported in this model.22 The increased swim
speed may be due to the recruitment of forelimbs, or
increased anxiety, which has also been reported before
in this model,23 unfortunately anxiety was not mea-
sured in these animals.
The MCAO rats also exhibited increased grip
strength, although this seems unexpected, it has been
reported before particularly in models of Parkinson’s
disease.24 It is postulated that this is due to a reduction
in the ability to initiate the movement to open the fore
paw and release the bar, akin to dystonia.
Although, appearing counter-intuitive these tests
still provide measures of dysfunction in these MCAO
rats, and therefore may be of potential use if replicated
in independent experiments. However, it is equally
necessary to identify the underlying causes of these
changes if the tests are to contribute to our understand-
ing of the disease and potential treatments rather than
simply provide further empirical measures of deﬁcit and
recovery.
Tests in which MCAO animals did not exhibit deficits
There were a number of tests that were not sensitive to
deﬁcits and even with increased sample sizes would be
unlikely to demonstrate diﬀerences between MCAO
and Control groups (Table 2). One such test was
amphetamine-induced rotations. Rotational bias to
amphetamine has been reported in the rat MCAO
model previously;6,25 however, these studies used
longer occlusions times (60–120min) resulting in
greater damage of the dorsal and medial striatum.
Amphetamine rotation has classically been associated
with dopamine denervation and re-innervation of the
dorsal striatum,26 whereas lateral lesions (the striatal
area predominantly aﬀected by MCAO) do not pro-
duce signiﬁcant rotational asymmetry.27
Of particular interest is the fact that both the adhe-
sive removal and cylinder tasks, which have been
employed extensively in experimental stroke research,
failed to reveal robust impairments at any of the tested
time points. With the adhesive removal task, testing
was only performed at one and two post-operative
months; therefore, there is the potential that deﬁcits
may have been seen at earlier time points. Indeed, the
magnitude of the somatosensory asymmetry has been
shown to be larger at acute time points (1–14 days) but
decreases in the chronic phase (21–30 days) using a
more severe permanent proximal occlusion of the
MCAO.28 The fact we observed a very small (but
non-signiﬁcant) bias in time to contact at one month,
would support the notion that spontaneous recovery on
this test may occur. Interestingly, the most common
caveat we experienced with this test was that the rats
(both Control and MCAO) ignored the stimuli and
took quite a long time to contact them. This could
potentially be due to the fact that the rats in this
study were very well handled and did not ﬁnd the
administration of the sticky tape aversive. A similar
eﬀect for the cylinder task, in that at chronic time
points limb use deﬁcits were not as pronounced, has
also been reported.28 Although, with the proximal per-
manent, MCAO model deﬁcits up to 28 days have been
seen in this task.29 With tests such as the cylinder that
rely on natural exploratory behaviour, there is the
potential confound that rodents lose interest with
time, particularly when well habituated to the environ-
ment, and this may also have been a contributing
factor.
Limitations
Some limitations of our experiments include the choice
of rat strain and the high incidence of sub-arachnoid
haemorrhage. The present study used Wistar rats and
these results may not transfer directly to other strains,
as there are signiﬁcant diﬀerences in the way diﬀerent
strains respond on behavioural tasks.11 Approximately,
20% of animals were excluded due to the lack of res-
toration of CBF following removal of the ﬁlament. In
all cases, animals were euthanized during surgery and a
sub-arachnoid haemorrhage was found on post-
mortem examination. High haemorrhage rates are
unfortunately not uncommon with this model.
However, we would like to point out that, within our
laboratory, we now use Doccol ﬁlaments (Doccol cor-
poration, USA), which has signiﬁcantly reduced this
adverse event. It should also be noted that behavioural
testing was carried out during the light cycle. Time of
testing has been shown to have an eﬀect on rodent per-
formance, particularly on cognitive tasks.30
Despite the fact that we aimed to produce small
lesions, the short occlusion time (30min) is associated
with a few limitations. For example, there was a high
rate of failure of the model (15% of animals were
excluded due to incomplete MCAO). While it is pos-
sible to increase the occlusion time to obtain larger
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infarcts, it is widely acknowledged that incomplete
MCAO is a common limitation of this model and not
completely dependent on occlusion duration. The smal-
ler lesions may also explain the lack of deﬁcits in some
tests and it is possible these tests are more suitable for
rodents with large, extensive infarcts.6,25 However, it is
important to point out that the ﬁlament model has the
potential to produce large lesions that could be con-
sidered to resemble malignant infarctions in humans.
In this situation, rodents often receive the poorest out-
come scores due to reluctance or the inability to par-
ticipate in the test. It has been argued that tests that
only detect deﬁcits at acute time points, or in animals
with extensive infarcts (such as neurological score) may
simply be more sensitive to morbidity outcomes and
not necessarily due to sensorimotor impairments. We
therefore feel that obtaining smaller lesions, in which
the overall impact on health was not as great a contri-
buting factor, was an advantage to our study.
Furthermore, tests that are robust enough to detect
deﬁcits in this smaller lesion model should be applicable
in the inverse situation, provided the health of the ani-
mals has recovered suﬃciently to participate. Finally, a
large number of behavioural tests were used in this
study, something that would not be recommended for
routine use or in a therapeutic study. In itself, this may
have acted as an intervention, enriching the rat’s envir-
onment and/or providing some degree of physical ther-
apy, and thereby reducing the magnitude of deﬁcits on
individual tasks that would have been seen if they had
been conducted alone. However, even if this was the
case, and the extensive testing provided some degree
of practice, compensation, neuroprotection or
enhanced endogenous plasticity, the aims were still
met as only tasks that are stable and robust would
have been signiﬁcant. Furthermore, in the clinical con-
text, it is best practice to provide stroke patients with
physical therapy, so the extensive training provided in
the present experiment will further help to avoid false
positives. On average, rats were given 8–15min of test-
ing each day, for 20–25 days in total, which is more
enrichment than received in a standard laboratory
environment, but it is also not considered excessive.
In conclusion, sensitive and robust tests that do not
show spontaneous recovery and are performed within
extended time windows are required if novel thera-
peutic strategies are to be successful. Here, we demon-
strate a number of tests, including lateralized stepping,
rotarod, apomorphine-induced rotations and the stair-
case task that were all able to detect long-term deﬁcits
in the relatively mild rat 30min ﬁlament MCAO model.
It is important to highlight that, even with these tests,
both the variability of the model and the inherent vari-
ability seen between animals when assessing behaviour,
necessitates large group sizes. To assist with this, we
provide sample size calculations from the data in the
present study to assist with future experimental design,
including testing of therapies with an eﬀect size of 50%.
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